These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 5830966)

  • 1. An examination of central actions characteristic of scopolamine: comparison of central and peripheral activity in scopolamine, atropine and some synthetic basic esters.
    Aparkes MW
    Psychopharmacologia; 1965 Jan; 7(1):1-19. PubMed ID: 5830966
    [No Abstract]   [Full Text] [Related]  

  • 2. Central and peripheral effects of anticholinergic compounds.
    Albanus L
    Acta Pharmacol Toxicol (Copenh); 1970; 28(4):305-26. PubMed ID: 5536020
    [No Abstract]   [Full Text] [Related]  

  • 3. The peripheral and central actions of some anticholinergic substances.
    Brimblecombe RW; Green DM
    Int J Neuropharmacol; 1968 Jan; 7(1):15-21. PubMed ID: 5639303
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of parachlorophenylalanine on nontolerant rats and of cholinergic blocking drugs on toleaant rats to morphine.
    Oka T; Nozaki M
    Jpn J Pharmacol; 1970 Sep; 20(3):455-7. PubMed ID: 5312655
    [No Abstract]   [Full Text] [Related]  

  • 5. Central and peripheral anticholinergic potency of some drugs antagonistic to anticholinesterase poisoning.
    Madill HD; Stewart WC; Savoie ML
    Can J Physiol Pharmacol; 1968 Jul; 46(4):559-65. PubMed ID: 5668200
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the central and peripheral effects of atropine, scopolamine and some synthetic atropine-like compounds.
    MEYERS FH; ABREU BE
    J Pharmacol Exp Ther; 1952 Apr; 104(4):387-95. PubMed ID: 14918058
    [No Abstract]   [Full Text] [Related]  

  • 7. "Comparison of antimuscarinic actions of anticholinergic agents in normal human volunteers".
    Gaitonde BB; Shaligram SV
    J Assoc Physicians India; 1971 Jan; 19(1):25-9. PubMed ID: 4997821
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative behavioral effects of several anticholinergic agents in rats.
    Pradhan SN; Roth T
    Psychopharmacologia; 1968; 12(4):358-66. PubMed ID: 5652217
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of anticholinergic psychotomimetic agents in mice and dogs.
    Cohen M
    Arch Int Pharmacodyn Ther; 1967 Oct; 169(2):412-20. PubMed ID: 6064569
    [No Abstract]   [Full Text] [Related]  

  • 10. THE IMPORTANCE OF LIPID-SOLUBILITY FOR THE CENTRAL ACTION OF CHOLINOLYTIC DRUGS.
    HERZ A; TESCHEMACHER H; HOFSTETTER A; KURZ H
    Int J Neuropharmacol; 1965 Jul; 4():207-18. PubMed ID: 14343875
    [No Abstract]   [Full Text] [Related]  

  • 11. Spectral analysis of heart rate variability as a quantitative measure of parasympatholytic effect--integrated pharmacokinetics and pharmacodynamics of three anticholinergic drugs.
    Scheinin H; Helminen A; Huhtala S; Grönroos P; Bosch JA; Kuusela T; Kanto J; Kaila T
    Ther Drug Monit; 1999 Apr; 21(2):141-51. PubMed ID: 10217331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of M- and N-central cholinolytics on the correlation between behavorial and electroencephalographic reactions of the ascending activating system of the brain stem].
    Krauz VA
    Farmakol Toksikol; 1968; 31(4):391-4. PubMed ID: 4386983
    [No Abstract]   [Full Text] [Related]  

  • 13. Electroencephalographic effects induced by choline pivaloyl esters in scopolamine-treated or nucleus basalis magnocellularis lesioned rats.
    Rispoli V; Rotiroti D; Carelli V; Liberatore F; Scipione L; Marra R; Tortorella S; Di Rienzo B
    Pharmacol Biochem Behav; 2004 Aug; 78(4):667-73. PubMed ID: 15301920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cholinergic antagonists on increases of spontaneous locomotor activity and body weight induced by the administration of morphine to tolerant rats.
    Oka T; Nozaki M; Hosoya E
    Psychopharmacologia; 1972; 23(3):231-7. PubMed ID: 5026946
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of scopolamine and atropine on the performance of an exercise-avoidance test by dogs.
    Mennear JH; Samuel GK; Joffe MH; Kodama JK
    Psychopharmacologia; 1966; 9(4):347-50. PubMed ID: 5996940
    [No Abstract]   [Full Text] [Related]  

  • 16. Central and peripheral actions of anticholinergic drugs when administered with triflupromazine.
    Brimblecombe RW; Green DM; Aldous FA; Thompson PB
    Neuropharmacology; 1971 Jan; 10(1):93-101. PubMed ID: 5569310
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral changes following disruption of central cholinergic pathways.
    Hamilton LW; Grossman SP
    J Comp Physiol Psychol; 1969 Sep; 69(1):76-82. PubMed ID: 5347370
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of scopolamine on performance on a geometric progressive ratio schedule.
    Stewart WJ; Blampied NM; Hughes RN
    Psychopharmacologia; 1974; 38(1):55-66. PubMed ID: 4854808
    [No Abstract]   [Full Text] [Related]  

  • 19. Central effects of anticholergic drugs measured by the apomorphine gnawing test in mice.
    Scheel-Krüger J
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):1-16. PubMed ID: 5467751
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibitory activities of several atropine-like drugs on the contraction of the digestive system and urinary bladder induced by the parasympathetic nerve stimulation in the dog].
    Kumada S; Otsuka M
    Nihon Yakurigaku Zasshi; 1970 Sep; 66(5):600-5. PubMed ID: 5529897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.